Trent LTD - Q1FY22 - Edited - 11-08-2021 - 10

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 7

HOLD

Result Update Trent Ltd Target Price


11th August 2021 Retail 990

Lockdown Impacts operations; Recovery Stands Protracted!


(CMP as of August10, 2021)
Trent Ltd. (Trent) witnessed a significant impact on the operations in Q1FY22 where recovery
was weak on a QoQ basis. Standalone revenue came at Rs 327 Cr (est. Rs 312 Cr) vs Rs 96 Cr CMP (Rs) 944
in Q1FY21, up 240% YoY on a lower base and ease in lockdown restrictions in April and Jun’21. Upside /Downside (%) 5%
Fashion Business (Westside and Zudio) operated for 46% of the trading days, up from 26% in
the corresponding previous period. However, by the quarter-end, the stores were operational for High/Low (Rs) 969/549
over 80% of the trading days. The latter part of the first quarter witnessed the lockdown Market cap (Cr) 33,575
relaxations, considerably aiding sentiment and improving consumer traction. Gross Margins at
Avg. daily vol. (6m) Shrs. 8,46,221
54% (our estimate: 47%) were significantly up YoY on account of better product mix and
improved sales due to lockdown relaxations and positive consumer sentiments in the latter part No. of shares (Cr) 35.5
of the quarter.
Consequently, EBITDA came in at Rs -32 Cr on account of lower sales and higher operational Shareholding (%)
expenditure despite savings in the rent expenses. Other income at Rs ~52 Cr includes Rs 35 Cr
Dec-20 Mar-21 Jun-21
on account of savings on rental cost in Q1FY22. It reported a net loss of ~Rs 90 Cr against a
loss of ~Rs 139 Cr in Q1FY21 on account of saving in the rent forming part of other income, Promoter 37.0 37.0 37.0
better cost management, and ease in lockdown leading to improved consumer sentiments. The FIIs 29.4 29.9 30.3
management highlighted over 90% of stores being operational on most days of a week with local
restrictions being increasingly eased in the recent weeks. In Aug’21, 184 Westside and 137 MFs / UTI 6.2 5.9 6.3
Zudio stores are operational by far. Furthermore, an additional 13 Westside and 12 Zudio stores Banks / FIs 0.0 0.0 0.0
are fitted out and are ready to open. These 25 stores are likely to open post restrictions easing
Others
up and/or local municipal approvals are in place. The company’s FY21 balance sheet remains 27.4 27.1 26.4
strong, aided by healthy CFO generation and it also turned debt-free as the company paid off its
existing debt. Online channel registered robust traction as it grew over 200% YoY in Q1FY22 Financial & Valuations
and for the first time, over 5% of Westside revenues were recorded through online channels. Y/E Mar (Rs. Cr) 2022E 2023E 2024E
Furthermore, with the management’s aim to retain its cost efficiencies, it is cautiously optimistic
Net Sales 4,019 5,127 6,155
on the recovery outlook and expects customer demand to rebound in Q2FY22.
EBITDA 695 923 1,114
We believe Trent is well-placed to bounce back post COVID-19 pandemic, driven by its success
Net Profit 147 271 438
in the ‘Westside’ concept (exclusive brands at competitive prices), the ramp-up of value fashion
format ‘Zudio’, sustainable margins (led by superior store metrics, supply chain optimization, and EPS (Rs.) 559 699 867
diligent focus on cost rationalization) backed by a strong balance sheet. We maintain our SOTP PER (x) 4.1 7.6 12.3
based TP to Rs 990 (Rs 790, previously) and maintain our current rating to HOLD given EV/EBITDA (x) 227.9 123.9 76.6
the negative impact of the second COVID-19 wave leading to lockdowns across states.
ROE (%) 52.3 39.4 32.4
Key result takeaways ROCE (%) 12.9 11.9 10.4
 Focus on store expansion and value fashion bodes well: In FY21, Trent added 9-
Westside stores, 53 Zudio stores, and 2 Landmarks stores despite COVID-19 led Growth Estimates (%)
disruptions. Given the quicker demand recovery in Tier 1 and 2 cities as against metros, Y/E Mar FY22E FY23E FY24E
Trent’s unwavering focus on store additions in Westside/Zudio formats beyond metros would
aid healthy recovery moving forward. Furthermore, an additional 13 Westside and 12 Zudio Sales 96 28 20
stores are fitted out and are ready to roll out as restrictions are eased and approvals are in EBITDA 241 33 21
place. With value fashion gaining more importance in the COVID-19 period owing to lower PAT - 84 62
discretionary spending, its aggressive store additions in its Zudio format (value fashion
format) would drive growth going ahead.
ESG disclosure Score**
 Healthy balance sheet to tide over tough times: Trent’s Mar’21 balance sheet was
strongly supported by healthy operating cash flow generation. Furthermore, it has turned Particulars Score
debt-free by repaying Rs 299 Cr debt in Q2FY21 (aided by Rs 950 Cr fundraise from its Environmental 44
parent Tata Sons). Trent intends to leverage its strong parentage and healthy balance sheet Social 48
to fund store additions plans as well as a tide over uncertain times. 32
Governance
 Consolidated Performance: For Q1FY22, consolidated revenues stood at Rs 492 Cr, up
98% YoY. The loss was at Rs 127 Cr vis-à-vis Rs 178 Cr in Q1FY21. The consolidated Total ESG Disclosure Score 17
results also incorporate the IndAS 116 lease accounting requirements. Its net effect on the Source: Bloomberg, Scale: 0.1-100
reported profit before tax for the quarter was an adverse impact of Rs 28 Cr.
 Improving membership: WestStyleClub loyalty program gained significant traction and Relative performance
registered the highest paid enrolments during the year. Given the attractive membership 140
benefits, the average bill values registered encouraging growth. As of 31 st March, the
company recorded over 6 Mn new members in the Westside loyalty program. 120

100
Key Financials (Standalone) 80
(Rs Cr) FY21 FY22E FY23E FY24E
60
Net Sales 2,048 4,019 5,127 6,155
40
EBITDA 204 695 923 1,114 Feb-20 Apr-20 Jul-20 Oct-20 Jan-21

Net Profit (45) 147 271 438 Trent BSE Sensex

EPS (Rs) (1.4) 4.1 7.6 12.3 Source: Capitaline, Axis Securities
PER (x) NA 227.9 123.9 76.6
EV/EBITDA (x) 178.6 52.3 39.4 32.4
Gaurav Uttrani
ROE (%) (1.8) 5.6 9.6 13.6 Research Analyst
ROCE (%) 3.3 9.2 12.4 14.7 Email: gaurav.uttrani@axissecurities.in

Source: Company, Axis Research


SuvarnaJoshi(Sr. Reseach Analyst)
Email:suvarna.joshi@axissecurities.in

1
Standalone Financial Highlights for Q1FY22
Axis Sec Axis Sec
Rs Cr Q1FY22 Q1FY21 YoY (%) Q4FY21 QoQ % FY21 FY20 YoY (%)
Est Var
Net Sales 327 312 5 96 240 774 (58) 2,048 3,178 (36)

Gross Profit 175 147 20 13 1,270 411 (57) 1,018 1,574 (35)

Gross Margins % 54 47 657 bps 13 4028 bps 53 40 bps 50 50 18 bps

Staff Cost 76 31 144 61 25 68 12 255 313 (19)

Other Operating expenses 131 84 55 71 84 207 (37) 375 698 (46)

EBITDA (32) 31 NA (119) NA 137 NA 388 563 (31)

EBITDA margins (%) (10) 10 NA (124) NA 18 NA 19 18 121 bps

Depreciation 62 58 7 59 6 62 1 236 231 2

Interest 69 57 20 57 19 62 11 238 238 (0)

Other Income 52 27 97 53 (1) 72 (28) 204 152 35

PBT before Exp. Items (110) (57) NA (182) NA 86 (229) 118 246 NA

Exceptional items (6) - NA - - (6) - (6) (0) -

PBT (117) (57) NA (182) NA 79 NA 112 246 NA

Tax (incl deferred) (26) (14) NA (43) NA 22 NA (21) 91 NA

PAT (90) (43) NA (139) NA 57 NA 133 155 NA

PAT margins (%) (28) (14) NA (145) NA 7 NA 6 5 NA

EPS (2) (1) NA (4) NA 2 NA (1) 4 NA

Source: Company; Axis Securities

2
Financials (Consolidated)

Profit & Loss (Rs Cr)


Y/E March FY21 FY22E FY23E FY24E
Net sales 2,048 4,019 5,127 6,155
Growth, % NA 96 28 20
Raw material expenses 1,030 2,049 2,599 3,121
Gross Profits 1,018 1,969 2,528 3,035
Gross Margins % 50 49 49 49
Employee expenses 255 398 508 609
Rent 184 257 328 394
Ads & promotions - - - -
Other Expenses 375 619 769 917
EBITDA 204 695 923 1,114
Growth, % NA 241 33 21
Margin, % 10.0 17.3 18.0 18.1
Depreciation 236 294 319 338
Other Income 204 100 92 96
EBIT 172 502 696 872
Growth, % (64) 191 39 25
Margin, % 8 12 14 14
Interest paid 238 305 334 287
Pre-tax profit (66) 197 362 585
Tax provided 21 (50) (91) (148)
Profit after tax (Adjusted) (45) 147 271 438
Growth, % NA NA 84 62
Source: Company, Axis Securities

Balance Sheet (Rs Cr)


Y/E March FY21 FY22E FY23E FY24E
Equity 2,516 2,610 2,827 3,212
Debt 2,903 2,903 2,903 2,903
Other Non-Current Liabilities 20 20 20 20
Total Liabilities 5,439 5,533 5,751 6,135

Net Fixed Assets 2,894 2,793 2,741 2,636


Net Intangible Assets 63 63 63 63
Other Non-Curr Assets 1,435 1,435 1,435 1,435
Inventories 395 716 913 1,096
Trade Receivables 21 22 28 34
Other Current Assets 830 860 960 1,060
Trade Payables 220 385 464 557
Other Current Liabilities 47 47 47 47
Net Current Assets 979 1,166 1,391 1,587
Cash & Equivalents 67 75 119 413
Net Tax Assets 2 2 2 2
Total Assets 5,439 5,533 5,751 6,135
Source: Company, Axis Securities

3
Cash Flow (Rs Cr)
Y/E March FY21 FY22E FY23E FY24E
Pre-tax profit (66) 197 362 585
Depreciation 236 294 319 338
Others 130 305 334 287
Opt Profits before working capital 300 796 1,015 1,210
Chg in working capital 113 (187) (225) (196)
Total tax paid (0) (50) (91) (148)
Cash flow from operating activities 413 559 699 867

Capex (103) (193) (268) (233)


Proceeds from sale of FA 22 - - -
Current & Non-Current Investments 97 - - -
Interest income 23 - - -
Income from Investments 5 - - -
Investment in Subsidiaries, JV, Associates (90) - - -
Repayment of Advances 7 - - -
Cash flow from investing activities (39) (193) (268) (233)

Free cash flow 310 366 431 634


Equity raised/(repaid) - - - -
Debt raised/(repaid) (78) - - -
Interest Paid (238) (305) (334) (287)
Dividend Paid (36) (53) (53) (53)
Cash flow from financing activities (351) (358) (387) (340)

Net chg in cash 23 8 44 294


Opening cash balance 44 67 75 119
Closing cash balance 67 75 119 413
Source: Company, Axis Securities

Ratio Analysis (%)


Y/E March FY21 FY22E FY23E FY24E
Per Share data
EPS (INR) (1.4) 4.1 7.6 12.3
Growth, % NA NA 83.8 61.7
Book NAV/share (INR) 71 73 80 90
DPS (INR) - 1.5 1.5 1.5
Return ratios
Avg Return on assets (%) (0.8) 2.7 4.8 7.4
Avg Return on equity (%) (1.8) 5.6 9.6 13.6
Avg Return on capital employed (%) 3.3 9.2 12.4 14.7
Working Capital Days
Inventory Days 70 65 65 65
Receivable Days 4 2 2 2
Payable Days 39 35 33 33
Working capital days 35 32 34 34
Valuation
PER (x) NA 227.9 123.9 76.6
Price/Book (x) 13.3 12.9 11.9 10.4
Div Yield (%) - 0.2 0.2 0.2
EV/Net sales (x) 17.8 9.1 7.1 5.9
EV/EBITDA (x) 178.6 52.3 39.4 32.4
EV/EBIT (x) 211.4 72.5 52.2 41.3
Source: Company, Axis Securities

4
Trent Ltd Price Chart and Recommendation History

(Rs)

Date Reco TP Research


28-Sep-20 BUY 786 Initiating Coverage
09-Nov-20 BUY 786 Result Update
05-Feb-21 BUY 786 Result Update
03-May-21 HOLD 790 Result Update
11-Aug-21 HOLD 990 Result Update

Source: Axis Securities

5
About the analyst

Analyst: Gaurav Uttrani

Contact Details: gaurav.uttrani@axissecurities.in

Sector: Agriculture and Consumer Discretionary

Analyst Bio: Gaurav Uttrani is a Chartered Accountant (ICAI) with about 2 years of experience in Equity market
and research.

About the analyst

Analyst: Suvarna Joshi

Contact Details: suvarna.joshi@axissecurites.in

Sector:FMCG, Consumption sector, Sp. Chemicals, Mid-Caps

Analyst Bio: Suvarna Joshi is MBA (Finance) from Mumbai University with about 10years of experience in Equity
market and research.

Disclosures:

The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations).
1. Axis Securities Ltd. (ASL) is a SEBI Registered Research Analyst having registration no. INH000000297. ASL, the Research Entity (RE) as defined in the
Regulations, is engaged in the business of providing Stock broking services, Depository participant services & distribution of various financial products. ASL is a
subsidiary company of Axis Bank Ltd. Axis Bank Ltd. is a listed public company and one of India’s largest private sector bank and has its various subsidiaries
engaged in businesses of Asset management, NBFC, Merchant Banking, Trusteeship, Venture Capital, Stock Broking, the details in respect of which are available on
www.axisbank.com.
2. ASL is registered with the Securities & Exchange Board of India (SEBI) for its stock broking & Depository participant business activities and with the Association of
Mutual Funds of India (AMFI) for distribution of financial products and also registered with IRDA as a corporate agent for insurance business activity.
3. ASL has no material adverse disciplinary history as on the date of publication of this report.
4. I/We, Gaurav Uttrani, (Chartered Accountant) and Suvarna Joshi, PGDBM (Finance), author/s and the name/s subscribed to this report, hereby certify that all of the
views expressed in this research report accurately reflect my/our views about the subject issuer(s) or securities. I/We (Research Analyst) also certify that no part of
my/our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. I/we or my/our relative or ASL does not
have any financial interest in the subject company. Also I/we or my/our relative or ASL or its Associates may have beneficial ownership of 1% or more in the subject
company at the end of the month immediately preceding the date of publication of the Research Report. Since associates of ASL are engaged in various financial
service businesses, they might have financial interests or beneficial ownership in various companies including the subject company/companies mentioned in this
report. I/we or my/our relative or ASL or its associate does not have any material conflict of interest. I/we have not served as director / officer, etc. in the subject
company in the last 12-month period.Any holding in stock – No
5. 5. ASL has not received any compensation from the subject company in the past twelve months. ASL has not been engaged in market making activity for the subject
company.
6. In the last 12-month period ending on the last day of the month immediately preceding the date of publication of this research report, ASL or any of its associates may
have:

Received compensation for investment banking, merchant banking or stock broking services or for any other services from the subject company of this research report and
/ or;
Managed or co-managed public offering of the securities from the subject company of this research report and / or;
Received compensation for products or services other than investment banking, merchant banking or stock broking services from the subject company of this research
report;
ASL or any of its associates have not received compensation or other benefits from the subject company of this research report or any other third-party in connection with
this report.
Term& Conditions:
This report has been prepared by ASL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential
and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior
written consent of ASL. The report is based on the facts, figures and information that are considered true, correct, reliable and accurate. The intent of this report is not
recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable. Such information has not been independently
verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are
subject to change without notice. The report is prepared solely for informational purpose and does not constitute an offer document or solicitation of offer to buy or sell or
subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers may receive this report at

6
the same time. ASL will not treat recipients as customers by virtue of their receiving this report.

DEFINITION OF RATINGS

Ratings Expected absolute returns over 12-18 months

BUY More than 10%

HOLD Between 10% and -10%

SELL Less than -10%

NOT RATED We have forward looking estimates for the stock but we refrain from assigning valuation and recommendation

UNDER REVIEW We will revisit our recommendation, valuation and estimates on the stock following recent events

NO STANCE We do not have any forward looking estimates, valuation or recommendation for the stock

Disclaimer:
Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to the recipient’s
specific circumstances. The securities and strategies discussed and opinions expressed, if any, in this report may not be suitable for all investors, who must make their own
investment decisions, based on their own investment objectives, financial positions and needs of specific recipient.

This report may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this report should make such investigations as it
deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved),
and should consult its own advisors to determine the merits and risks of such an investment. Certain transactions, including those involving futures, options and other
derivatives as well as non-investment grade securities involve substantial risk and are not suitable for all investors. ASL, its directors, analysts or employees do not take
any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not
restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. Past
performance is not necessarily a guide to future performance. Investors are advice necessarily a guide to future performance. Investors are advised to see Risk Disclosure
Document to understand the risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-
looking statements are not predictions and may be subject to change without notice.

ASL and its affiliated companies, their directors and employees may; (a) from time to time, have long or short position(s) in, and buy or sell the securities of the
company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities or earn brokerage or other compensation or act as a market maker in
the financial instruments of the company(ies) discussed herein or act as an advisor or investment banker, lender/borrower to such company(ies) or may have any other
potential conflict of interests with respect to any recommendation and other related information and opinions. Each of these entities functions as a separate, distinct and
independent of each other. The recipient should take this into account before interpreting this document.

ASL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result, the recipients of this report
should be aware that ASL may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based on any
specific merchant banking, investment banking or brokerage service transactions. ASL may have issued other reports that are inconsistent with and reach different
conclusion from the information presented in this report. The Research reports are also available & published on AxisDirect website.

Neither this report nor any copy of it may be taken or transmitted into the United State (to U.S. Persons), Canada, or Japan or distributed, directly or indirectly, in the United
States or Canada or distributed or redistributed in Japan or to any resident thereof. If this report is inadvertently sent or has reached any individual in such country,
especially, USA, the same may be ignored and brought to the attention of the sender. This report is not directed or intended for distribution to, or use by, any person or
entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to
law, regulation or which would subject ASL to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible
for sale in all jurisdictions or to certain category of investors.

The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of the views
expressed in the report. The Company reserves the right to make modifications and alternations to this document as may be required from time to time without any prior
notice. The views expressed are those of the analyst(s) and the Company may or may not subscribe to all the views expressed therein.
Copyright in this document vests with Axis Securities Limited.
Axis Securities Limited, Corporate office: Unit No. 2, Phoenix Market City, 15, LBS Road, Near Kamani Junction, Kurla (west), Mumbai-400070, Tel No. – 022-40508080/
022-61480808, Regd. off.- Axis House, 8th Floor, Wadia International Centre, PandurangBudhkar Marg, Worli, Mumbai – 400 025. Compliance Officer: AnandShaha,
Email: compliance.officer@axisdirect.in, Tel No: 022-42671582.SEBI-Portfolio Manager Reg. No. INP000000654

You might also like